Theseus Pharmaceuticals Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	27,242	26,508	25,395	24,494	19,820	14,429	Upgrade
Revenue Growth (YoY)	5.45%	4.38%	3.68%	23.58%	37.36%	-17.03%	Upgrade
Cost of Revenue	10,357	9,934	9,593	9,122	7,763	6,376	Upgrade
Gross Profit	16,885	16,574	15,802	15,372	12,057	8,053	Upgrade
Selling, General & Admin	12,712	12,467	12,051	11,668	9,235	7,049	Upgrade
Research & Development	648	631	593	600	579	552	Upgrade
Other Operating Expenses	-10	-5	1	-11	-4	8	Upgrade
Operating Expenses	13,350	13,093	12,645	12,257	9,810	7,609	Upgrade
Operating Income	3,535	3,481	3,157	3,115	2,247	444	Upgrade
Interest Expense	-278	-253	-198	-156	-141	-141	Upgrade
Interest & Investment Income	97	97	87	30	30	24	Upgrade
Earnings From Equity Investments	3	3	-1	6	3	1	Upgrade
Currency Exchange Gain (Loss)	48	20	-7	12	-11	-19	Upgrade
Other Non Operating Income (Expenses)	-29	-24	-23	-19	-8	-4	Upgrade
EBT Excluding Unusual Items	3,376	3,324	3,015	2,988	2,120	305	Upgrade
Merger & Restructuring Charges	-65	-65	-4	-7	-	-10	Upgrade
Gain (Loss) on Sale of Investments	-	-	12	41	-	-	Upgrade
Gain (Loss) on Sale of Assets	4	-	-2	1	-2	-6	Upgrade
Legal Settlements	-10	-10	-	-	-	-	Upgrade
Other Unusual Items	42	42	14	8	62	24	Upgrade
Pretax Income	3,347	3,291	3,035	3,031	2,180	313	Upgrade
Income Tax Expense	835	800	609	751	582	164	Upgrade
Earnings From Continuing Operations	2,512	2,491	2,426	2,280	1,598	149	Upgrade
Minority Interest in Earnings	-131	-132	-137	-128	-150	-64	Upgrade
Net Income	2,381	2,359	2,289	2,152	1,448	85	Upgrade
Net Income to Common	2,381	2,359	2,289	2,152	1,448	85	Upgrade
Net Income Growth	3.84%	3.06%	6.37%	48.62%	1603.53%	-92.11%	Upgrade
Shares Outstanding (Basic)	456	454	448	442	439	436	Upgrade
Shares Outstanding (Diluted)	462	460	451	446	445	439	Upgrade
Shares Change (YoY)	1.36%	2.05%	1.15%	0.04%	1.47%	-0.48%	Upgrade
EPS (Basic)	5.22	5.20	5.11	4.87	3.30	0.20	Upgrade
EPS (Diluted)	5.15	5.13	5.08	4.83	3.25	0.19	Upgrade
EPS Growth	2.25%	0.98%	5.18%	48.62%	1610.54%	-92.21%	Upgrade
Free Cash Flow	3,363	3,352	3,330	3,211	3,515	2,303	Upgrade
Free Cash Flow Per Share	7.28	7.29	7.39	7.21	7.89	5.25	Upgrade
Dividend Per Share	3.950	3.950	3.950	3.230	2.510	2.230	Upgrade
Dividend Growth	-	-	22.29%	28.68%	12.56%	-	Upgrade
Gross Margin	61.98%	62.52%	62.22%	62.76%	60.83%	55.81%	Upgrade
Operating Margin	12.98%	13.13%	12.43%	12.72%	11.34%	3.08%	Upgrade
Profit Margin	8.74%	8.90%	9.01%	8.79%	7.31%	0.59%	Upgrade
Free Cash Flow Margin	12.35%	12.65%	13.11%	13.11%	17.73%	15.96%	Upgrade
EBITDA	5,626	5,562	5,175	5,112	3,927	2,024	Upgrade
EBITDA Margin	20.65%	20.98%	20.38%	20.87%	19.81%	14.03%	Upgrade
D&A For EBITDA	2,091	2,081	2,018	1,997	1,680	1,580	Upgrade
EBIT	3,535	3,481	3,157	3,115	2,247	444	Upgrade
EBIT Margin	12.98%	13.13%	12.43%	12.72%	11.34%	3.08%	Upgrade
Effective Tax Rate	24.95%	24.31%	20.07%	24.78%	26.70%	52.40%	Upgrade
Advertising Expenses	-	1,820	1,799	1,811	1,534	1,156	Upgrade

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.